BANK OF MONTREAL /CAN/ - PROVECTUS BIOPHARMACEUTICALS ownership

PROVECTUS BIOPHARMACEUTICALS's ticker is PVCT and the CUSIP is 74373P108. A total of 44 filers reported holding PROVECTUS BIOPHARMACEUTICALS in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BANK OF MONTREAL /CAN/ ownership history of PROVECTUS BIOPHARMACEUTICALS
ValueSharesWeighting
Q3 2016$1,000
-75.0%
11,4990.0%0.00%
Q2 2016$4,000
-33.3%
11,499
-34.3%
0.00%
Q1 2016$6,0000.0%17,499
+2.9%
0.00%
Q4 2015$6,000
-33.3%
17,0000.0%0.00%
Q3 2015$9,0000.0%17,0000.0%0.00%
Q2 2015$9,000
-35.7%
17,0000.0%0.00%
Q1 2015$14,0000.0%17,0000.0%0.00%
Q4 2014$14,000
-17.6%
17,0000.0%0.00%
Q3 2014$17,000
+21.4%
17,0000.0%0.00%
Q2 2014$14,00017,0000.00%
Other shareholders
PROVECTUS BIOPHARMACEUTICALS shareholders Q4 2015
NameSharesValueWeighting ↓
HOME FEDERAL BANK OF TENNESSEE 100,000$8,5000.00%
LEE DANNER & BASS INC 50,000$40.00%
LBMC INVESTMENT ADVISORS, LLC 22,000$1,7160.00%
Atlas Wealth LLC 26,620$2,2490.00%
ACADEMY CAPITAL MANAGEMENT INC/TX 20,000$1,6900.00%
HUNTINGTON NATIONAL BANK 1$00.00%
View complete list of PROVECTUS BIOPHARMACEUTICALS shareholders